NEW YORK, NY / ACCESSWIRE / November 29, 2024 / If you suffered a loss on your Visa Inc. (NYSE:V) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/visa-inc-lawsuit-submission-form?prid=114122&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) […]

NEW YORK, NY / ACCESSWIRE / November 29, 2024 / Patelco Credit Union ("Patelco") recently disclosed that it suffered a data breach that compromised the sensitive personal data of more than 1 millioncustomers.This data breach has led to concerns over the security of sensitive persona information entrusted to Patelco. WHAT’S THIS ABOUT? On June 29,

LOS ANGELES, CA / ACCESSWIRE / November 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Iris Energy Limited ("Iris" or "the Company") (NASDAQ:IREN) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by

LOS ANGELES, CA / ACCESSWIRE / November 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Huntington Ingalls Industries, Inc. ("Huntington Ingalls" or "the Company") (NYSE:HII) for violations of the securities laws. According to the Complaint, the Company made false

NEW YORK, Nov. 29, 2024 (GLOBE NEWSWIRE) — Blade Air Mobility, Inc. (Nasdaq: BLDE, “Blade” or the “Company”), a technology-powered air mobility platform, today announced that Rob Wiesenthal, Chief Executive Officer, will present at the 2024 UBS Global Technology and AI Conference on Wednesday, December 4, 2024 at 12:15 pm MT. A webcast of the

SAN FRANCISCO and WALTHAM, Mass., Nov. 29, 2024 (GLOBE NEWSWIRE) — Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, chronic obstructive pulmonary disease (COPD) and other I&I

PHILADELPHIA, Nov. 29, 2024 (GLOBE NEWSWIRE) — The law firm of Barrack, Rodos & Bacine announces that a class action lawsuit has been filed on behalf of investors who purchased stock in PACS Group, Inc. (NYSE: PACS), from April 11, 2024 through and including November 5, 2024 (the “Class Period”). WHAT’S THIS ABOUT?On November 4,

(NASDAQ:BLDE), NEW YORK, Nov. 29, 2024 (GLOBE NEWSWIRE) — Blade Air Mobility, Inc. (Nasdaq: BLDE, “Blade” or the “Company”), a technology-powered air mobility platform, today announced that Rob Wiesenthal, Chief Executive Officer, will present at the 2024 UBS Global Technology and AI Conference on Wednesday, December 4, 2024 at 12:15 pm MT. A webcast of

(NasdaqGM:APGE), SAN FRANCISCO and WALTHAM, Mass., Nov. 29, 2024 (GLOBE NEWSWIRE) — Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, chronic obstructive pulmonary disease (COPD) and other

(NYSE:PACS), PHILADELPHIA, Nov. 29, 2024 (GLOBE NEWSWIRE) — The law firm of Barrack, Rodos & Bacine announces that a class action lawsuit has been filed on behalf of investors who purchased stock in PACS Group, Inc. (NYSE: PACS), from April 11, 2024 through and including November 5, 2024 (the “Class Period”). WHAT'S THIS ABOUT?On November